What is the CVSS score of CVE-2024-37122?

CVE-2024-37122 has a CVSS 3.1 base score of 4.8 (Medium). CVSS vector: CVSS:3.1/AV:N/AC:L/PR:H/UI:R/S:C/C:L/I:L/A:N. EPSS exploitation probability: 0.3%.

Accordions CVE-2024-37122

MEDIUM

Cross-site Scripting (XSS) (CWE-79)

2024-07-22 audit@patchstack.com

XSS Accordions

4.8

CVSS 3.1 · NVD

Severity by source

NVD PRIMARY

4.8 MEDIUM

AV:N/AC:L/PR:H/UI:R/S:C/C:L/I:L/A:N

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:N/AC:L/PR:H/UI:R/S:C/C:L/I:L/A:N

Attack Vector

Network

Attack Complexity

Low

Privileges Required

High

User Interaction

Required

Scope

Changed

Confidentiality

Low

Integrity

Low

Availability

None

Lifecycle Timeline

CVE Published

Jul 22, 2024 - 10:15 nvd

MEDIUM 4.8

DescriptionNVD

Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting') vulnerability in Biplob Adhikari Accordions allows Stored XSS.This issue affects Accordions: from n/a through 2.3.5.

AnalysisAI

Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting') vulnerability in Biplob Adhikari Accordions allows Stored XSS.3.5. Rated medium severity (CVSS 4.8), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

Technical ContextAI

This vulnerability is classified as Cross-Site Scripting (XSS) (CWE-79), which allows attackers to inject malicious scripts into web pages viewed by other users. Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting') vulnerability in Biplob Adhikari Accordions allows Stored XSS.3.5. Affected products include: Oxilab Accordions. Version information: through 2.3.5..

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Sanitize all user input, use Content-Security-Policy headers, encode output contextually (HTML, JS, URL). Use frameworks with built-in XSS protection.